AtriCure, Inc. Research And Development Expense

• AtriCure, Inc. showed an increase of +3.2% in Research And Development Expense from 2024 to 2025.
• This data is from AtriCure, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), AtriCure, Inc.'s Research And Development Expense has grown by 769.1%.
• Historical annual values: Fiscal year 2025: $99.21 million | Fiscal year 2024: $96.18 million | Fiscal year 2023: $73.92 million | Fiscal year 2022: $57.34 million | Fiscal year 2021: $48.51 million | Fiscal year 2020: $43.07 million | Fiscal year 2019: $41.23 million | Fiscal year 2018: $34.72 million | Fiscal year 2017: $34.14 million | Fiscal year 2016: $35.82 million | Fiscal year 2015: $25.74 million | Fiscal year 2014: $18.60 million | Fiscal year 2013: $13.44 million | Fiscal year 2012: $12.15 million | Fiscal year 2011: $11.86 million | Fiscal year 2010: $11.53 million | Fiscal year 2009: $11.41 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026